Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mehra Anand
Relationship:   Director
City:   Menlo Park
State:   CA
   
Insider Summary:
  
   
Companies Owned :   11    
Direct Shares   11,769,795    

Indirect Shares

   6,925,513      
Direct Value   $208,649,962    

Indirect Value

   $97,703,528      
Total Shares   18,695,308      
Total Value   $306,353,490      


Aerie Pharmaceuticals Inc $25,925 Alimera Sciences Inc $12,206 aTyr Pharma Inc $683,749 Synlogic Inc $829,972 Aclaris Therapeutics, Inc. $45,671 Iterum Therapeutics Plc $2,589,771 Principia Biopharma Inc $203,922,710 Galera Therapeutics, Inc. $539,958 Aerie Pharmaceuticals Inc $25,925 Alimera Sciences Inc $12,206 aTyr Pharma Inc $683,749 Synlogic Inc $829,972 Aclaris Therapeutics, Inc. $45,671 Iterum Therapeutics Plc $2,589,771 Principia Biopharma Inc $203,922,710 Galera Therapeutics, Inc. $539,958
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aerie Pharmaceuticals Inc AERI Director 2015-04-10 1,700 2015-04-15 469,591    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2014-09-12 40,020 2014-09-12 506,270    Premium*  
            Ocugen Ord Shs OCGN 10% Owner 2014-12-08 0 2014-12-08 2,077,040    Premium*  
            Spark Therapeutics, Inc. ONCE Director 2019-12-17 0 2019-12-17 0    Premium*  
            aTyr Pharma Inc LIFE 10% Owner 2015-05-12 1,866,126 2015-05-12 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-06 2,974,811 2015-10-05 0    Premium*  
            Aclaris Therapeutics, Inc. ACRS Director 2023-06-02 38,704 2018-10-22 1,911,573    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2018-05-30 1,726,514 2018-05-30 0    Premium*  
            Principia Biopharma Inc PRNB 10% Owner 2018-09-18 2,038,208 2018-09-18 0    Premium*  
            Galera Therapeutics, Inc. GRTX 10% Owner 2019-11-12 3,083,712 2019-11-12 0    Premium*  
            Merus Nv MRUS Director 0 2020-01-01 1,961,039    Premium*  
* Premium Members only  

Records found :    78         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2014-09-12 4 A $0.00 $0 D/D 40,020 40,020 0 -
OCGN Ocugen Ord Shs 10% Owner   –       –       •   2014-12-08 4 A $0.00 $0 I/I 1,572,083 1,572,083 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2015-02-04 4 A $0.00 $0 I/I 1,893,576 1,893,576 0 -
AERI Aerie Pharmaceuticals Inc Director   –       •      –    2015-04-10 4 A $0.00 $0 D/D 1,700 1,700 0 -
LIFE aTyr Pharma Inc 10% Owner   –       –       •   2015-05-12 4 A $0.00 $0 D/D 1,546,126 1,546,126 0 -
SYBX Synlogic Inc 10% Owner   –       –       •   2015-10-05 4 A $0.00 $0 D/D 1,827,828 1,827,828 0 -
SYBX Synlogic Inc 10% Owner   –       –       •   2015-10-06 4 A $0.00 $0 D/D 289,841 2,117,669 0 -
ACRS Aclaris Therapeutics, Inc... Director   –       •       •   2015-10-13 4 A $0.00 $0 I/I 1,880,390 1,880,390 0 -
ITRM Iterum Therapeutics Plc 10% Owner   –       –       •   2018-05-30 4 A $0.00 $0 D/D 1,226,514 1,226,514 0 -
PRNB Principia Biopharma Inc 10% Owner   –       –       •   2018-09-18 4 A $0.00 $0 D/D 1,768,208 1,768,208 0 -
GRTX Galera Therapeutics, Inc. 10% Owner   –       –       •   2019-11-12 4 A $0.00 $0 D/D 2,333,712 2,333,712 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-05-31 4 AS $60.00 $30,000 I/I (500) 1,434,966 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-01 4 AS $60.03 $1,360,580 I/I (22,665) 1,412,301 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-03 4 AS $60.00 $276,720 I/I (4,612) 1,407,689 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-04 4 AS $60.00 $27,120 I/I (452) 1,407,237 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-08 4 AS $60.47 $6,047 I/I (100) 1,407,137 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-10 4 AS $60.02 $414,138 I/I (6,900) 1,400,237 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2016-08-11 4 AS $60.14 $1,387,679 I/I (23,063) 1,377,174 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2017-02-03 4 AS $65.06 $1,452,790 I/I (22,330) 882,656 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2017-02-06 4 AS $65.00 $65,650 I/I (1,010) 881,646 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2017-02-07 4 AS $65.04 $129,690 I/I (1,994) 879,652 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2017-02-09 4 AS $65.06 $2,433,960 I/I (37,411) 842,241 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2017-02-14 4 AS $65.02 $61,769 I/I (950) 841,291 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2017-02-15 4 AS $65.03 $2,048,250 I/I (31,497) 809,794 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2017-02-16 4 AS $65.01 $188,529 I/I (2,900) 806,894 0 -
  78  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us